<DOC>
	<DOCNO>NCT01015014</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability pharmacokinetic profile antibacterial compound treatment hospital acquire Gram negative infection .</brief_summary>
	<brief_title>Safety , Pharmacokinetics ( PK ) Tolerability Study Novel Drug Treatment Bacterial Infections</brief_title>
	<detailed_description>Single-center , randomize , placebo-controlled , double-blind study determine safety , tolerability pharmacokinetic profile compound single multiple dos young healthy male .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Negative Bacterial Infections</mesh_term>
	<criteria>Young healthy male , 1845 year ( inclusive ) age Healthy judge responsible physician clinically significant abnormality Surgically sterile OR agree abstain sexual intercourse female partner OR agree use condom spermicide sexual intercourse female partner use another form contraception Body weight 50 kg ( Body Mass Index 19 30 kg/m2 ) Nonsmokers Willing able comply study instruction commit followup visit Ability understand , agree sign study Informed Consent Form ( ICF ) History serious adverse reaction hypersensitivity drug ; know allergy test product ( ) components test product ( ) ; history hypersensitivity allergic reaction study preparation describe Investigator 's Brochure Any clinically significant central nervous system , cardiac , pulmonary , metabolic , renal , hepatic gastrointestinal condition Abnormal physical finding clinical significance screen examination baseline History orthostatic hypotension Clinically significant abnormal laboratory value Presence history allergy require acute chronic treatment 12 lead ECG abnormalities Major surgical intervention within 6 month study Has positive prestudy Hepatitis B surface antigen ; positive hepatitis C ( HCV ) antibody detectable HCV ribonucleic acid ( RNA ) ; positive HIV antibody result Use prescription nonprescription drug Has history regular alcohol consumption Loss 500 mL blood 3 month period study People follow vegetarian vegan diet Symptoms significant somatic mental illness four week period precede drug administration History drug abuse dependence within 12 month study The subject positive prestudy alcohol urine drug screen Concurrent participation another drug device research study within 60 day post participation another drug device study Considered Investigator unsuitable candidate study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Gram negative</keyword>
	<keyword>bacteria</keyword>
	<keyword>infection</keyword>
</DOC>